Open Access. Powered by Scholars. Published by Universities.®
- Institution
-
- The Texas Medical Center Library (7488)
- Thomas Jefferson University (1279)
- University of Kentucky (763)
- University of Texas MD Anderson Cancer Center (520)
- Aga Khan University (411)
-
- Providence (383)
- Edith Cowan University (244)
- LSU Health New Orleans (216)
- Children's Mercy Kansas City (174)
- Old Dominion University (161)
- Wayne State University (148)
- University of Nebraska Medical Center (126)
- Chapman University (106)
- OhioHealth (96)
- Zucker School of Medicine at Hofstra/Northwell (95)
- Marshall University (93)
- Corewell Health (89)
- University of Texas Rio Grande Valley (85)
- Valparaiso University (84)
- University of Nevada, Las Vegas (82)
- University of South Florida (80)
- City University of New York (CUNY) (75)
- Himmelfarb Health Sciences Library, The George Washington University (72)
- Advocate Health - Midwest (68)
- Rowan University (64)
- Philadelphia College of Osteopathic Medicine (56)
- Lehigh Valley Health Network (51)
- Virginia Commonwealth University (49)
- Parkview Health (44)
- Grand Valley State University (38)
- Keyword
-
- Humans (5570)
- Female (2236)
- Male (1772)
- Animals (1587)
- Middle Aged (1234)
-
- Mice (1230)
- Adult (1138)
- Aged (1106)
- Neoplasms (955)
- Tumor (817)
- Cancer (724)
- Carcinoma (651)
- Immunotherapy (626)
- Cell Line, Tumor (590)
- Cell Line (582)
- Retrospective Studies (568)
- Mutation (496)
- Lung Neoplasms (478)
- Biomarkers (452)
- Breast Neoplasms (444)
- Tumor Microenvironment (435)
- Breast cancer (416)
- Leukemia (416)
- Prognosis (395)
- Antineoplastic Agents (390)
- Treatment Outcome (390)
- Antineoplastic Combined Chemotherapy Protocols (382)
- Child (350)
- Aged, 80 and over (347)
- Melanoma (337)
- Publication Year
- Publication
-
- Faculty, Staff and Student Publications (6711)
- Faculty, Staff and Students Publications (599)
- Markey Cancer Center Faculty Publications (481)
- Department of Medical Oncology Faculty Papers (321)
- Articles, Abstracts, and Reports (290)
-
- OncoLog MD Anderson's Report to Physicians (All issues) Archives (275)
- Department of Radiation Oncology Faculty Papers (203)
- School of Medicine Faculty Publications (169)
- Research outputs 2022 to 2026 (161)
- Dissertations and Theses (Open Access) (127)
- Department of Cancer Biology Faculty Papers (121)
- Manuscripts, Articles, Book Chapters and Other Papers (113)
- Kimmel Cancer Center Faculty Papers (107)
- Newsletter: A Report to Physicians of Texas Archives (107)
- Journal Articles (95)
- Oncology Articles (89)
- Journal of Mind and Medical Sciences (76)
- Department of Pathology and Laboratory Medicine (75)
- USF Tampa Graduate Theses and Dissertations (74)
- Journal of Patient-Centered Research and Reviews (68)
- Pharmacy Faculty Articles and Research (68)
- Publications and Research (67)
- Bodine Journal (63)
- Conference Presentation Abstracts (63)
- Journal Articles: Eppley Institute (59)
- Wayne State University Associated BioMed Central Scholarship (58)
- Research outputs 2014 to 2021 (55)
- Rowan-Virtua Research Day (50)
- Internal Medicine Faculty Publications (49)
- Section of Haematology/Oncology (47)
- Publication Type
- File Type
Articles 13951 - 13980 of 14285
Full-Text Articles in Medical Specialties
Oncolog, Volume 46, Number 03, March 2001, Dawn Chalaire, Beth Notzon, Janette Weaver, Leonard A. Zwelling Md, Mba, Kerry L. Wright
Oncolog, Volume 46, Number 03, March 2001, Dawn Chalaire, Beth Notzon, Janette Weaver, Leonard A. Zwelling Md, Mba, Kerry L. Wright
OncoLog MD Anderson's Report to Physicians (All issues) Archives
- Researchers Examine Link Between Stress and Response to Cancer Treatment
- Emotional Side Effects: Section of Behavioral Medicine in Department of Pediatrics Helps Patients and Their Families Cope with Cancer
- House Call: Getting the Facts About Clinical Trials
- DiaLog: Where Patient Care and Research Meet, by Leonard A. Zwelling, MD, MBA, Vice President for Research Administration
- Moving Toward Recovery: Exercise Video Features Adolescents with Cancer
Flow Cytometric Analysis Of Childhood Leukemias, R. Z. Yusuf, Shahid Pervez, S. A. Aziz, Mohammad Khurshid
Flow Cytometric Analysis Of Childhood Leukemias, R. Z. Yusuf, Shahid Pervez, S. A. Aziz, Mohammad Khurshid
Department of Pathology and Laboratory Medicine
Objective: To collect demographic data for childhood (less than 15 years) leukemias in Karachi, describe the accuracy of the cell surface markers routinely used in the flow cytometric analysis of leukemic cells and arrive at an ideal panel of antibodies for analyzing leukemic samiples.
Materials and Methods: Data from 62 consecutive cases of childhood leukemias referred to the Department of Pathology, Aga Khan University Hospital. (AKUH) between January 1995 and December 1998 was analyzed using Epi Info Version 6. Flow cytometry on all samples was performed using standard protocols.
Results: The mean age of patients was 8.2 years and 49 …
Oncolog, Volume 46, Number 02, February 2001, Sunni Hosemann, Kerry L. Wright, Janet M. Bruner Md
Oncolog, Volume 46, Number 02, February 2001, Sunni Hosemann, Kerry L. Wright, Janet M. Bruner Md
OncoLog MD Anderson's Report to Physicians (All issues) Archives
- Specialized Training and Techniques of Pathologists Lead to Targeted Therapies
- Protocols: Studies Examine High-Dose Chemotherapy for Breast Cancer
- High-Dose Chemotherapy for Breast Cancer: Completion of Clinical Trials Necessary
- DiaLog: Many Specialties, One Goal, by Janet M. Bruner, MD, Chairman, Department of Pathology
- House Call: Support Groups Offer Patients a Helping Hand
- Study Reveals Types of Diagnostic Errors and Their Costs
2000 Cancer Care Annual Report, Children's Mercy Hospital
2000 Cancer Care Annual Report, Children's Mercy Hospital
Cancer Center Annual Reports
Annual report of cancer care and oncology services at the Children's Mercy Hospital, Kansas City MO, a pediatric medical center.
Is Extended Volume Of External Beam Irradiation Beneficial In Post-Esophagectomy High Risk Patients Receiving Combined Chemoradiation Therapy?, E. Yu, A. R. Dar, R. Ash, G. Videtic, P. Truong, L. Stitt, A. Tomiak, M. Vincent, R. Malthaner, I. Craig, E. Brecevic, W. Kocha, R. Inculet, M. Lefcoe
Is Extended Volume Of External Beam Irradiation Beneficial In Post-Esophagectomy High Risk Patients Receiving Combined Chemoradiation Therapy?, E. Yu, A. R. Dar, R. Ash, G. Videtic, P. Truong, L. Stitt, A. Tomiak, M. Vincent, R. Malthaner, I. Craig, E. Brecevic, W. Kocha, R. Inculet, M. Lefcoe
Oncology Presentations
OBJECTIVE: To assess the value of extended volume irradiation with anastomotic coverage in high risk resected esophageal cancer patients.
METHOD: A retrospective study was undertaken at LRCC from 1989-1999 for high risk resected esophageal cancer patients. Adjuvant treatments consisted of 4 cycles of chemotherapy (epirubicin/fluorouracil/cisplatin or cisplatin/fluorouracil), and local regional irradiation with or without coverage of the anastomotic site. Radiation dose ranged from 45-60Gy at 1.8-2.0 Gy/fraction given with initial anterior-posterior/posterior-anterior arrangement with either extended (with anastomotic coverage) or small (without anastomotic coverage) field followed by oblique fields for boost.
RESULT: One hundred eighty-eight charts were reviewed. Seventy-two patients were …
Department Of Radiation Oncology And Kimmel Cancer Center, Thomas Jefferson University, The Intronic G13964c Variant In P53 Is Not A High-Risk Mutation In Familial Breast Cancer In Australia., Anna Marsh, Amanda B Spurdle, Bruce C Turner, Sian Fereday, Heather Thorne, Gulietta M Pupo, Graham J Mann, John L Hopper, Joseph F Sambrook, Georgia Chenevix-Trench
Department Of Radiation Oncology And Kimmel Cancer Center, Thomas Jefferson University, The Intronic G13964c Variant In P53 Is Not A High-Risk Mutation In Familial Breast Cancer In Australia., Anna Marsh, Amanda B Spurdle, Bruce C Turner, Sian Fereday, Heather Thorne, Gulietta M Pupo, Graham J Mann, John L Hopper, Joseph F Sambrook, Georgia Chenevix-Trench
Department of Radiation Oncology Faculty Papers
BACKGROUND: Mutations in BRCA1 and BRCA2 account for approximately 50% of breast cancer families with more than four affected cases, whereas exonic mutations in p53, PTEN, CHK2 and ATM may account for a very small proportion. It was recently reported that an intronic variant of p53--G13964C--occurred in three out of 42 (7.1%) 'hereditary' breast cancer patients, but not in any of 171 'sporadic' breast cancer control individuals (P = 0.0003). If this relatively frequent occurrence of G13964C in familial breast cancer and absence in control individuals were confirmed, then this would suggest that the G13964C variant plays a role in …
Oncolog, Volume 46, Number 01, January 2001, Kerry L. Wright, Dawn Chalaire, Emil J. Freireich Md
Oncolog, Volume 46, Number 01, January 2001, Kerry L. Wright, Dawn Chalaire, Emil J. Freireich Md
OncoLog MD Anderson's Report to Physicians (All issues) Archives
- New Melanoma Staging System Reflects Key Prognostic Factors
- House Cell: Preventing Cancer: Food for Thought
- Educational Conferences Explore Issues Related to Cancer Care and Research
- DiaLog: Leukemia: Setting the "Stage" for Effective Treatments, by Emil J. Freireich, MD, Professor, Department of Leukemia
- Updated M. D. Anderson Website Designed to Meet the Online Needs of Patients and Physicians
Cellular Senescence: Ex Vivo P53-Dependent Asymmetric Cell Kinetics., Lakshmi Rambhatla, Shirley A. Bohn, Patrizia B. Stadler, Jonathan T. Boyd, Ronald A. Coss, James L. Sherley
Cellular Senescence: Ex Vivo P53-Dependent Asymmetric Cell Kinetics., Lakshmi Rambhatla, Shirley A. Bohn, Patrizia B. Stadler, Jonathan T. Boyd, Ronald A. Coss, James L. Sherley
Department of Radiation Oncology Faculty Papers
Although senescence is a defining property of euploid mammalian cells, its physiologic basis remains obscure. Previously, cell kinetics properties of normal tissue cells have not been considered in models for senescence. We now provide evidence that senescence is in fact the natural consequence of normal in vivo somatic stem cell kinetics extended in culture. This concept of senescence is based on our discovery that cells engineered to conditionally express the well-recognized tumor suppressor protein and senescence factor, p53, exhibit asymmetric cell kinetics. In vivo, asymmetric cell kinetics are essential for maintenance of somatic stem cells; ex vivo, the same cell …
Epstein-Barr Virus Serology In The Diagnosis Of Nasopharyngeal Carcinoma From Sarawak, Madeline Wong Mei Fong
Epstein-Barr Virus Serology In The Diagnosis Of Nasopharyngeal Carcinoma From Sarawak, Madeline Wong Mei Fong
Student Works (2000-2009)
The Epstein-Barr virus (EBV) is closely associated with nasopharyngcal carcinoma (NPC). The role(s) of EBV in NPC remains unclear but antibodies to two EBV proteins namely the viral capsid antigen (VCA) and early antigen (EA), are clinically useful diagnostic markers of NPC. The NPC scenario in Malaysia has been based on studies done on West Malaysian patients but not much has been described for NPC in Sarawak, East Malaysia. In this study, 164 NPC sera from newly histologically confirmed NPC patients were collected from the Radiotherapy Unit of Kuching General Hospital, Sarawak prior to radiotherapy. One hundred and forty seven …
Oncolog, Volume 45, Number 12, December 2000, Sunni Hosemann, Noelle Heinze, Alison Ruffin
Oncolog, Volume 45, Number 12, December 2000, Sunni Hosemann, Noelle Heinze, Alison Ruffin
OncoLog MD Anderson's Report to Physicians (All issues) Archives
- And Cancer Too: Treating Cancer Alongside Other Conditions
- Compass: Clinical Practice Guidelines
- New Study Measures the Effects of Mood and Hereditary Tendencies to Smoke on Tobacco Cessation
- House Call: How to Talk with Your Doctor
- Controlling Infections in Patients with Neutropenia Remains a Challenge
Retinoblastoma Tells The Story Of Our Health Care System, Irshad Soomro, Muhammad Nadeem Khan, Suhail Muzaffar, Naila Kayani, Shahid Pervez, Akbar Shah Hussainy, Rashida Ahmed, Sheema H. Hasan
Retinoblastoma Tells The Story Of Our Health Care System, Irshad Soomro, Muhammad Nadeem Khan, Suhail Muzaffar, Naila Kayani, Shahid Pervez, Akbar Shah Hussainy, Rashida Ahmed, Sheema H. Hasan
Department of Pathology and Laboratory Medicine
Objective:
To review cases of retinoblastoma.
Setting:
Department of Pathology Aga Khan University Hospital Karachi.
Method:
Twenty three specimens from cases of retinoblastoma received over a period of eight years were routinely processes and stained with haematoxylin and Eosin stain Other stains were used for tuberculosis and melanin. Immunochemistry was resorted to in undifferentiated tumors.
Results:
Over 60% cases of retinoblastoma were diagnosed after 5 years and nine cases showed involvement of opti-nerve.
Conclusion:
Late diagnosis of retinoblastoma effects the stage of the tumors and the prognisis.
Oncolog, Volume 45, Number 11, November 2000, Rebecca Gershenson Smith, Kerry L. Wright, Kris Muller, Sima Jeha Md
Oncolog, Volume 45, Number 11, November 2000, Rebecca Gershenson Smith, Kerry L. Wright, Kris Muller, Sima Jeha Md
OncoLog MD Anderson's Report to Physicians (All issues) Archives
- Program Addresses Medical, Psychosocial Needs of Young People with Cancer
- DiaLog: Coming of Age ... with Cancer, by Sima Jeha, MD, Medical Director, Adolescent and Young Adult Program
- House Call: Cancer Screening: Early Detection Does Make a Difference
- Endostatin: Phase I Trial Yields Promising Preliminary Results
- Molecular Radiosensitizers Target Proliferation and Apoptosis Pathways in Tumor Cells
Induction Of Apoptosis In Human Prostate Cancer Cells By Resveratrol, Gary Zulfikar Morris
Induction Of Apoptosis In Human Prostate Cancer Cells By Resveratrol, Gary Zulfikar Morris
Chemistry & Biochemistry Theses & Dissertations
Recently attention has been brought to trans-resveratrol's {TR) anticancer activity, as determined through a number of cultured cancer cell models. This activity was attributed to TR behaving as an estrogen, and the orientation of TR' s hydroxyl groups. Based on this work it was of interest to determine whether TR would also be toxic in prostate cancer cells; if toxic, did TR induce necrosis or apoptosis in the cells; was it toxic through hormone mediated pathways; and were TR's hydroxyl groups responsible for its biological activity. To this end, cellular viability was assessed in two different prostate cancer cell …
Oncolog, Volume 45, Number 10, October 2000, Jude Richard, Dawn Chalaire, Kerry L. Wright, Alfred A. Merwald Dmin
Oncolog, Volume 45, Number 10, October 2000, Jude Richard, Dawn Chalaire, Kerry L. Wright, Alfred A. Merwald Dmin
OncoLog MD Anderson's Report to Physicians (All issues) Archives
- Early Consultations with Specialists Increase Patients' Voice Restoration Options After Total Laryngectomy
- Protocols: Small Cell Lung Cancer Clinical Trials
- House Call: Unconventional Cancer Treatments: Many Promises but Little Evidence
- Reunions Give Lung Cancer Survivors an Opportunity to Celebrate
- DiaLog: Treating Mind, Body, and Spirit, by The Rev. Alfred A. Merwald, D. Min., Director of Chaplaincy and Pastoral Education
- Experience Leads to More Effective Treatment for Limited-Stage Small Cell Lung Cancer
Oncolog, Volume 45, Number 09, September 2000, Mariann Crapanzano, Kerry L. Wright, David L. Callender Md
Oncolog, Volume 45, Number 09, September 2000, Mariann Crapanzano, Kerry L. Wright, David L. Callender Md
OncoLog MD Anderson's Report to Physicians (All issues) Archives
- Multidisciplinary Care Improves Treatment, Enhances Quality of Life for Patients with Colorectal Cancer
- DiaLog: Treating Cancer with a Team Approach, by David L. Callender, MD, Senior Vice President and Chief Medical Officer
- Cervical Cancer Prevention: Could Spectroscopy Steal the Spot"light"?
- Virtual Colonoscopy a Potential Screening Reality
- Protocols: Clinical Trials for Colorectal Cancer
- Compass: Clinical Practice Guidelines
- House Call: Sharing Personal Stories: Books Written by People with Cancer
Interactions Of Igf-Ii And Cathepsin D In Mcf-7 Breast Cancer Cells, Jesika S. Faridi
Interactions Of Igf-Ii And Cathepsin D In Mcf-7 Breast Cancer Cells, Jesika S. Faridi
Loma Linda University Electronic Theses, Dissertations & Projects
A primary role of the IGF-II/M6P receptor is to target lysosomal enzymes from the golgi to the lysosomes. This receptor has distinct binding sites for IGF-II and M6P, however, reciprocal interactions between these ligands have been observed (Kiess et al. 1989, 1990). Since IGF-II modulates the routing of cathepsin D in MCF-7 cells by blocking the intracellular binding of cathepsin D to the IGF-II/M6P receptor (De León et al. 1996), we hypothesized that expressing a mutant form of IGF-II that does not bind the IGF-II/M6P receptor will not interfere with lysosomal enzyme trafficking.
In our present study, we report the …
Vitamin A And Cancer, Richard M. Niles
Vitamin A And Cancer, Richard M. Niles
Biochemistry and Microbiology
Vitamin A, its physiological metabolites and synthetic derivatives (retinoids) have been shown to have protective effects against the development of certain types of cancer. In addition, pharmacological amounts of retinoids have been used with some success in the treatment of a few human tumors. The chemoprevention effect of retinoids is most likely exerted at the tumor promotion phase of carcinogenesis. Retinoids block tumor promotion by either inhibiting proliferation, inducing apoptosis, inducing differentiation, or a combination of these actions. Clinically, isotretinoin (13-cis-retinoic acid) significantly decreases the incidence of second primary tumors in patients with head and neck cancer and also reduces …
Oncolog, Volume 45, Number 07/08, July/August 2000, Kerry L. Wright, Dawn Chalaire, Rebecca D. Pentz Phd
Oncolog, Volume 45, Number 07/08, July/August 2000, Kerry L. Wright, Dawn Chalaire, Rebecca D. Pentz Phd
OncoLog MD Anderson's Report to Physicians (All issues) Archives
- Advances Allow Expanded Use of Allogeneic Stem Cell Transplantation
- Use of Umbilical Cord Blood Expands Option of Transplantation to More Children
- House Call: Meeting Your Own Needs While Caring For Someone Else
- Protecting the Interests of Young Donors, by Rebecca Pentz, PhD, Clinical Ethicist
- Protocols: Clinical Trials of Allogeneic Stem Cell Transplants
Oncolog, Volume 45, Number 06, June 2000, Kerry L. Wright, Margaret E. Goode, Jack Roth Md, Gary S. Clayman Md, Dds
Oncolog, Volume 45, Number 06, June 2000, Kerry L. Wright, Margaret E. Goode, Jack Roth Md, Gary S. Clayman Md, Dds
OncoLog MD Anderson's Report to Physicians (All issues) Archives
- Newly Organized Ophthalmology Section Expands Treatment of Ocular Malignancies
- Turning Knowledge Into Effective Gene Therapies, by Jack A. Roth, MD, Professor, Department of Thoracic and Cardiovascular Surgery, and Gary S. Clayman, MD, DDS, Associate Professor, Head and Neck Surgery
- Microarrays Reduce Time, Labor, and Cost of DNA Analysis
- New DNA Microarray Technology Could Speed Up Discovery of the Genetic Causes of Lung Cancer
- House Call: Virtual Health: Finding Reliable Medical Resources on the Internet
- Clinical Practice Guidelines: Case Report: Ovarian Cancer
- Protocols: Studies Aim to Detect and Treat Ocular Malignancies
Locus Of Control, Coping, And Anticipatory Nausea In Women With Breast Cancer, Melinda L. Nielsen
Locus Of Control, Coping, And Anticipatory Nausea In Women With Breast Cancer, Melinda L. Nielsen
Loma Linda University Electronic Theses, Dissertations & Projects
Many cancer patients experience adverse chemotherapy-related side effects. The present study examined whether the perception that one can control and effectively cope with her treatment for breast cancer mitigate against any nausea and vomiting that she may experience in anticipation of chemotherapy treatments. Seventy-five women with breast cancer completed the Multidimensional Health Locus of Control Scale - Form C, the Krantz Health Opinion Survey, the Ways of Coping Scale - Revised, and the Morrow Assessment of Nausea and Emesis. As hypothesized, internal health locus of control was significantly positively related to positive reappraisal coping strategies. This relationship was moderated by …
Audit Of Lymph Node Biopsies In Suspected Cases Of Lymphoproliferative Malignancies: Implications On Tissue Diagnosis And Patient Management, Mohammad Zeeshan Qamar, Mehrukh Mujib, Shahid Pervez
Audit Of Lymph Node Biopsies In Suspected Cases Of Lymphoproliferative Malignancies: Implications On Tissue Diagnosis And Patient Management, Mohammad Zeeshan Qamar, Mehrukh Mujib, Shahid Pervez
Department of Pathology and Laboratory Medicine
Aims: To carry out an audit ascertaining the importance of condition of lymph node specimen, submission of clinical history including site of biopsy and imrnunohistochemcial studies on conclusiveness of diagnosis made.
Methodology: Computer records of the Aga Khan University Hospital, Histopathology Laboratory were used to analyze all cases of lymphoproliferative malignancies presented at the hospital from 1992 to 1998.
Results: Out of a total of 466 cases studied, in 283 (61%) the lymph nodes were fragmented. The site of biopsy was mentioned in 361 (77.5%) cases with the cervical region forming the most common site (56.5%). A clinical history was …
Effect Of Receptor-Selective Retinoids On Growth And Differentiation Pathways In Mouse Melanoma Cells, Sejal H. Desai, Goran Boskovic, Linda L. Eastham, Marcia Dawson, Richard M. Niles
Effect Of Receptor-Selective Retinoids On Growth And Differentiation Pathways In Mouse Melanoma Cells, Sejal H. Desai, Goran Boskovic, Linda L. Eastham, Marcia Dawson, Richard M. Niles
Biochemistry and Microbiology
Treatment of B16 mouse melanoma cells with all-trans-retinoic acid (ATRA) results in inhibition of cell proliferation and induction of differentiation. Accompanying these events is an induction of retinoic acid receptor β (RARβ) expression, an increase in protein kinase Cα (PKCα) expression, and enhanced activator protein-1 (AP-1) transcriptional activity. These cells express nuclear RARα and RARγ and nuclear retinoid X receptors (RXR) α and β constitutively. We tested the ability of receptor-selective retinoids to induce the biochemical changes found in ATRA-treated melanoma cells and also tested their effectiveness in decreasing anchorage-dependent and -independent growth. The RXR-selective ligand (2E,4E)-6-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)-3,7-dimethyl-2,4,6-octatrienoic acid (SR11246) was …
Electrically Mediated Plasmid Dna Delivery To Hepatocellular Carcinomas In Vivo, L. Heller, M. J. Jaroszeski, D. Coppola, C. Pottinger, R. Gilbert, Richard Heller
Electrically Mediated Plasmid Dna Delivery To Hepatocellular Carcinomas In Vivo, L. Heller, M. J. Jaroszeski, D. Coppola, C. Pottinger, R. Gilbert, Richard Heller
Bioelectrics Publications
Gene therapy by direct delivery of plasmid DNA has several advantages over viral gene transfer, but plasmid delivery is less efficient. In vivo electroporation has been used to enhance delivery of chemotherapeutic agents to tumors in both animal and human studies. Recently, this delivery technique has been extended to large molecules such as plasmid DNA. Here, the successful delivery of plasmids encoding reporter genes to rat hepatocellular carcinomas by in vivo electroporation is demonstrated.
Oncolog, Volume 45, Number 05, May 2000, Kerry L. Wright, Stephanie Deming, Gordon B. Mills Md, Phd
Oncolog, Volume 45, Number 05, May 2000, Kerry L. Wright, Stephanie Deming, Gordon B. Mills Md, Phd
OncoLog MD Anderson's Report to Physicians (All issues) Archives
- Early Detection of Melanoma Spread May Increase Survival Benefits of Adjuvant Therapy
- No Easy Answers: Women at Increased Risk for Breast Cancer Face Difficult Choices
- DiaLog: Understanding Risk: A Prerequisite for Making Informed Decisions, by Gordon B. Mills, MD, PhD, Chairman, Department of Molecular Therapeutics
- House Call: Looking for Trouble: How to Spot Signs of Melanoma
- Protocols: Melanoma Clinical Trials
- Biochemotherapy Means Hope for Patients with Advanced Melanoma
The Relationship Between Health Attitudes, Beliefs, Health Locus Of Control And Use Of Breast Cancer Screening Modalities In Elderly Hispanic Women, Debra Kay Gillett, Rosamaria Ortiz
The Relationship Between Health Attitudes, Beliefs, Health Locus Of Control And Use Of Breast Cancer Screening Modalities In Elderly Hispanic Women, Debra Kay Gillett, Rosamaria Ortiz
Theses and Dissertations - UTB/UTPA
A non-experimental design was used to examine the relationship between health attitudes, beliefs, locus of control and the use of breast cancer screening modalities in elderly Hispanic women in this pilot study. Leininger's Theory of Culture Care Diversity and Universality and the Health Belief Model were the supporting theoretical frameworks. Research was conducted at the Amigos del Valle senior centers in Hidalgo County and included 52 English-speaking elderly Hispanic volunteer participants. Instruments used for data collection were the Health Care Attitudes and Beliefs Scale and the Multidimensional Health Locus of Control Scale. Results of this study revealed that there appears …
Dietary Fish Oil Sensitizes A549 Lung Xenografts To Doxorubicin Chemotherapy, W. Elaine Hardman, Mary Pat Moyer, Ivan L. Cameron
Dietary Fish Oil Sensitizes A549 Lung Xenografts To Doxorubicin Chemotherapy, W. Elaine Hardman, Mary Pat Moyer, Ivan L. Cameron
Biochemistry and Microbiology
A549 xenografts were allowed to grow in nude mice to about 5 mm in diameter, then diets were changed to modified AIN-76 diets containing 19% wt/wt. fish oil (FO) or 20% wt./wt. com oil (CO). Ten days later dietary ferric citrate (0.3% wt./dry wt.) was added and doxoribicin (DOX) treatment (3.6 mg/kg i.v. each of the 5 days for 18 days) commenced. Treatment with DOX halted the growth of tumors in the CO fed mice. However, in those mice, which consumed FO or FO with ferric citrate, treatment with DOX caused significant tumor regression.
Oncolog, Volume 45, Number 04, April 2000, Don Norwood, Kerry L. Wright, Ellen R. Gritz Phd, Alexander V. Prokhorov Md, Phd
Oncolog, Volume 45, Number 04, April 2000, Don Norwood, Kerry L. Wright, Ellen R. Gritz Phd, Alexander V. Prokhorov Md, Phd
OncoLog MD Anderson's Report to Physicians (All issues) Archives
- Rise in Incidence, Associated Diseases Complicate Screening for Esophageal Cancer
- DiaLog: Preventing Cancers of the Upper Aerodigestive Trad: Challenges for Clinicians, by Ellen R. Gritz, PhD, Professor and Chair, Department of Behavioral Science, and Alexander V. Prokhorov, MD, PhD, Assistant Professor, Department of Behavioral Science
- House Call: Gene Therapy: Changing the Way Cancer Cells Behave
- Efforts in Thyroid Cancer Treatment Include Initiation of Multicenter Clinical Trials
- Preclinical Studies Examine Strategies to Fight Rare Forms of Thyroid Cancer
- Protocols: Clinical Trials for Esophageal Cancer
Oncolog, Volume 45, Number 03, March 2000, Jude Richard, Kerry L. Wright, Charles S. Cleeland Phd
Oncolog, Volume 45, Number 03, March 2000, Jude Richard, Kerry L. Wright, Charles S. Cleeland Phd
OncoLog MD Anderson's Report to Physicians (All issues) Archives
- Dental Oncologists Prepare Patients with Head and Neck Cancer for Radiation Therapy
- DiaLog: Nurses Bring Personal Touch to Clinical Research, by Charles S. Cleeland, PhD, Professor, Pain Research Group, Division of Anesthesiology and Critical Care
- House Call: Coping with Chemotherapy
- Radiofrequency Ablation Surpasses Cryoablation as the Treatment of Choice for Localized, Unresectable Liver Malignancies
Oncolog, Volume 45, Number 02, February 2000, Kerry L. Wright, Mariann Crapanzano
Oncolog, Volume 45, Number 02, February 2000, Kerry L. Wright, Mariann Crapanzano
OncoLog MD Anderson's Report to Physicians (All issues) Archives
- National Cooperation Leads to New Standard of Treatment for Cervical Cancer
- House Call: Stress and Cancer: What's the Connection?
- Researchers Study Hormone Intervention Therapy to Prevent Treatment-Induced Sterility
- Protocols: Cervical Cancer Clinical Trials
- Regular Pap Smears Still Key to Preventing Cervical Cancer
Intimate Partner Violence And Cervical Neoplasia, Ann L. Coker, Maureen Sanderson, Mary Kay Fadden, Lucia Pirisi
Intimate Partner Violence And Cervical Neoplasia, Ann L. Coker, Maureen Sanderson, Mary Kay Fadden, Lucia Pirisi
CRVAW Faculty Journal Articles
Intimate partner violence (IPV) is associated with a range of adverse physical health outcomes, including chronic and infectious diseases. An emerging literature suggests that partner violence and specifically sexual violence may be associated with an increased risk of cervical neoplasia. To assess the risk of preinvasive and invasive cervical cancer in a cross-sectional study of women screened for IPV by type, frequency and duration, 1152 women ages 18–65 were recruited from family practice clinics in 1997–1998. They were screened for IPV during a brief in-clinic interview, and health history and current status were assessed in a follow-up interview. Of 1152 …